RxDoctor Payments Data

Evelyn Hahn

Physician Assistant · Salisbury, MDNPI 1043756117

Payments from drug & device makers

$1,170in general payments, 2019–2025

Across 36 payments — averaging $32.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$460
  • Astellas Pharma US Inc$149
  • Pfizer$64
  • Sanofi$59
  • Merck$55
  • Regeneron Healthcare Solutions, Inc.$52
  • plus $331 from 11 others

What the payments were for

  • Food & beverage$95181%
  • Education$21919%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,170 in reported general payments places this provider in the 80th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$45,809
Medicare patients
314
Services billed
800

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav45$386
Albuterol Sulfate HfaAlbuterol Sulfate15$322
Doxycycline Monohydrate33$229
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst13$168
Cephalexin28$142
Mupirocin17$133
Amoxicillin21$70
Azithromycin17$35
Prednisone23$31
PaxlovidNirmatrelvir/Ritonavir19$0

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPaxlovid$64$019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Salisbury

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →